TSLP is released from the airway epithelium in response to allergens, viral infection, and type 2 cytokines, and it activates dendritic cells and ILC2s to promote Th2 inflammation, positioning it upstream of the IgE, IL-5, and IL-13 pathways [10,11]. Here, IL13 is linked to viral infectious disease.